Efficacy of sacubitril/valsartan versus olmesartan in Japanese patients with essential hypertension: a randomized, double-blind, multicenter study by Rakugi, Hiromi, Kario, Kazuomi, Yamaguchi, Masako, Sasajima, Takayoshi, Gotou, Hiromi, Zhang, Jack

Get full text

Real-life long-term safety and effectiveness of omalizumab in Japanese pediatric patients with severe allergic asthma: A post-marketing surveillance by Nakamura, Noriko, Kashitani, Yuka, Yoshisue, Hajime, Nagasaki, Makoto, Sasajima, Takayoshi

Get full text

Real-world safety and effectiveness of omalizumab in Japanese patients with chronic spontaneous urticaria: A post-marketing surveillance study by Hide, Michihiro, Fukunaga, Atsushi, Suzuki, Takayuki, Nakamura, Noriko, Kimura, Mine, Sasajima, Takayoshi, Kiriyama, Junna, Igarashi, Atsuyuki

Get full text

Real-world Safety and Efficacy of Indacaterol/Glycopyrronium in Japanese Patients with Chronic Obstructive Pulmonary Disease: A 52-week Post-marketing Surveillance by Kato, Chihiro, Yoshisue, Hajime, Nakamura, Noriko, Sasajima, Takayoshi

Get full text

Real-world Safety and Efficacy of Indacaterol Maleate in Patients with Chronic Obstructive Pulmonary Disease: Evidence from the Long-term Post-marketing Surveillance in Japan by Taniguchi, Tomoko, Wang, Dong, Yoshisue, Hajime, Nagasaki, Makoto, Sasajima, Takayoshi

Get full text

Real-life long-term safety and effectiveness of omalizumab in Japanese pediatric patients with severe allergic asthma : A post-marketing surveillance by Noriko Nakamura, Yuka Kashitani, Hajime Yoshisue, Makoto Nagasaki, Takayoshi Sasajima

Get full text

Real-world safety and efficacy of omalizumab in patients with severe allergic asthma: A long-term post-marketing study in Japan by Adachi, Mitsuru, Kozawa, Masanari, Yoshisue, Hajime, Lee Milligan, Ki, Nagasaki, Makoto, Sasajima, Takayoshi, Miyamoto, Terumasa, Ohta, Ken

Get full text

Real-world Safety and Efficacy of indacaterol Maleate in Patients with Chronic Obstructive Pulmonary Disease: Evidence from the Long-term Post-marketing Surveillance in Japan by Taniguchi, Tomoko, Wang, Dong, Yoshisue, Hajime, Nagasaki, Makoto, Sasajima, Takayoshi

Get full text

Real-world Safety and Efficacy of Indacaterol/Glycopyrronium in Japanese Patients with Chronic Obstructive Pulmonary Disease: A 52-week Post-marketing Surveillance by Kato, Chihiro, Yoshisue, Hajime, Nakamura, Noriko, Sasajima, Takayoshi

Get full text

Real-World Safety and Efficacy of Glycopyrronium Bromide in Japanese Patients with COPD: A 52-Week Post-Marketing Surveillance by Kato, Chihiro, Wang, Dong, Nakamura, Noriko, Sasajima, Takayoshi, Yoshisue, Hajime

Get full text

Real-life safety and efficacy of omalizumab in Japanese patients with severe allergic asthma who were subjected to dosing table revision or expansion: A post-marketing surveillance by Asano, Koichiro, Sumi, Kazuya, Yoshisue, Hajime, Nakamura, Noriko, Nagasaki, Makoto, Sasajima, Takayoshi, Matsumoto, Hisako

Get full text

Long term safety and efficacy of ligelizumab in the treatment of Japanese patients with chronic spontaneous urticaria by Takahashi, Hidetoshi, Fukunaga, Atsushi, Hayama, Koremasa, Sasajima, Takayoshi, Fujishige, Ayako, Ichishita, Ryohei, Tomimatsu, Naoko, Hua, Eva, Varanasi, Vineeth, Burciu, Alis, Hide, Michihiro, Severin, Thomas

Get full text

Safety and effectiveness of fingolimod in Japanese patients with multiple sclerosis: Results of a post‐marketing surveillance study by Sato, Noriko, Wakimoto, Koji, Kato, Kyoko, Susuta, Yutaka, Ueda, Kengo, Satou, Yoshihisa, Sasajima, Takayoshi, Kira, Jun‐ichi

Get full text